this paper reports the results of a double-blind comparison of fixed daily doses of 6 mg of alprazolam , 2 mg of alprazolam , 225 mg of imipramine , and placebo for 8 weeks in 81 patients who met dsm-iii criteria for panic disorder with or without agoraphobia .
C0002333
alprazolam
C0001818
agoraphobia